|
VPS33B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.377160E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.400800E-04 |
| Normal-vs-Stage2 |
1.217940E-02 |
| Normal-vs-Stage3 |
3.022400E-04 |
| Normal-vs-Stage4 |
5.9532999999945E-05 |
| Stage1-vs-Stage2 |
8.911800E-01 |
| Stage1-vs-Stage3 |
3.434600E-01 |
| Stage1-vs-Stage4 |
1.122840E-01 |
| Stage2-vs-Stage3 |
6.388800E-01 |
| Stage2-vs-Stage4 |
3.052600E-01 |
| Stage3-vs-Stage4 |
4.519400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.790300E-04 |
| Normal-vs-AfricanAmerican |
5.493800E-02 |
| Normal-vs-Asian |
1.148010E-02 |
| Caucasian-vs-AfricanAmerican |
5.844000E-01 |
| Caucasian-vs-Asian |
4.180400E-01 |
| AfricanAmerican-vs-Asian |
9.493200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.704100E-03 |
| Normal-vs-Female |
1.176370E-04 |
| Male-vs-Female |
5.118800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.169690E-04 |
| Normal-vs-Age(41-60Yrs) |
3.982800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.429700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.196780E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.817200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.344800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.399800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.259400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.332400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.092000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.426790E-01 |
| Classical-VS-Follicular |
2.802300E-02 |
| Classical-VS-Other |
1.917620E-01 |
| Classical-VS-Normal |
2.080700E-03 |
| Tall-VS-Follicular |
7.524400E-01 |
| Tall-VS-Other |
6.145200E-01 |
| Tall-VS-Normal |
1.279780E-03 |
| Follicular-VS-Other |
7.879800E-01 |
| Follicular-VS-Normal |
9.96070000000016E-05 |
| Other-VS-Normal |
2.435900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.197900E-03 |
| Normal-vs-N1 |
1.50580000024547E-07 |
| N0-vs-N1 |
4.643000E-03 |
|
|
